简介

Dan Boeglin is an experienced corporate and transactional lawyer with deep expertise in the life sciences industry. Dan partners with clients in support of their development and growth strategies.

Transaction Counsel

For the past 20 of his more than 30 years in practice, Dan has specialized in supporting the business development teams of leading life sciences companies like Zimmer Biomet Holdings, Eli Lilly and Company, and Baxter Healthcare, and the senior management teams of successful biotechnology companies such as Endocyte, Inc., CoLucid Pharmaceuticals and Marcadia Biotech. He has been lead counsel in more than 100 strategic transactions, including domestic and international acquisitions and divestitures, in-licensing and out-licensing transactions, exclusive distribution arrangements, product development and collaboration agreements, multi-party joint ventures, strategic investments, and venture capital financings.

Outside General Counsel

Dan has served as outside general counsel to more than a dozen biotechnology and medical device companies developing life-saving medicines and technologies in fields such as oncology, neuroscience, cardiology and diabetes.

Industry Training

Dan completed the Biotechnology for Business program at Duke University in 2004.

资质

执业资格

Indiana

教育

University of Virginia School of Law
J.D. (1985)

Indiana University, Bloomington
B.S. with highest distinction (1982)

见解和活动

其他角度
  • Best Practices for Selecting the Deal Structure and Negotiating Your Most Beneficial Collaborative Agreement Yet
    Life Sciences Collaborative Agreements and Acquisitions, American Conference Institute, San Francisco, July 2011

领导力和社区

市民活动

  • Indiana University Kelley School of Business — Alumni Association Board, 1992-98 (President, 1996-97); Dean's Advisory Council; and Johnson Center for Entrepreneurship and Innovation Board

荣誉

  • The Best Lawyers in America — Biotechnology Law, 2001-19, and Corporate Law, 2001-19 (Indianapolis Lawyer of the Year, 2017)
  • Chambers USA: America's Leading Lawyers for Business — Corporate/M&A, 2004-18
  • Super Lawyers — Mergers & Acquisitions, 2004-18
Faegre Baker Daniels 网站使用 Cookie 来提升您的浏览体验。